JCE vs RILY

The deterministic health profile is severely compromised with a Piotroski F-Score of 1/9, indicating significant fundamental weakness. However, this is contrasted by a strong value proposition, with the stock trading at a P/E of 5.93 and below its intrinsic value of $18.90. While long-term price performance is robust (+72.6% over 5 years), the current technical trend is heavily bearish (10/100). The investment case rests on a high dividend yield of 8.49% and deep value, offset by poor short-term momentum and weak health metrics.

RILY exhibits severe financial instability, highlighted by a weak Piotroski F-Score of 2/9 and a critical negative Price-to-Book ratio of -0.92, indicating negative shareholders' equity. While the P/E ratio of 1.04 and high YoY revenue growth (75.8%) appear attractive on the surface, they are likely value traps given the company's erratic earnings history and lack of fundamental health. The absence of an Altman Z-Score and Graham Number further underscores the inability to apply standard valuation models to this distressed balance sheet. Despite a recent 1-year price surge, the long-term trend is deeply negative, and the financial foundation is precarious.